Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation-Reference-Cited by-同舟云学术

Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation

Published:2012-11 Issue:5 Volume:207 Page:398.e1-398.e8
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Caritis Steve N.,Sharma Shringi,Venkataramanan Raman,Hankins Gary D.,Miodovnik Menachem,Hebert Mary F.,Umans Jason G.,Benedetti Thomas,Mattison Donald,Zajicek Anne,Fischer Dawn,Jackson Aimee

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference21 articles.

1. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate;Meis;N Engl J Med,2003

2. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins;Rouse;N Engl J Med,2007

3. Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial;Caritis;Obstet Gynecol,2009

4. Randomized controlled trial of progesterone treatment for preterm birth prevention in nulliparous women with cervical length less than 30 mm;Grobman;Am J Obstet Gynecol,2012

5. ACOG committee opinion no. 419: use of progesterone to reduce preterm birth;Obstet Gynecol,2008

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of Developmental 17‐OHPC Exposure on the Mesocorticolimbic Serotonergic and Dopaminergic Pathways and Adolescent Mood–Related Behavior in Rats;Developmental Psychobiology;2024-08-20

2. Anatomy of an FDA Drug Recall: The 17α-Hydroxyprogesterone Accelerated Approval and Withdrawal Processes;Current Obstetrics and Gynecology Reports;2024-07-30

3. Developmental exposure to 17-α-hydroxyprogesterone caproate disrupts decision-making in adult female rats: A potential role for a dopaminergic mechanism;Hormones and Behavior;2024-07

4. The dosing regimen for 17-hydroxyprogesterone caproate was suboptimal: lessons for future pharmacotherapy for pregnant women;American Journal of Obstetrics and Gynecology;2024-04

5. Vaginal progesterone for the prevention of recurrent spontaneous preterm birth;American Journal of Obstetrics & Gynecology MFM;2023-10